Head-to-head · Cost-Efficiency Index
NuuVim vs Zappy Health
Two GLP-1 programs on the bench, scored on the same six factors. Here's how their real cost of ownership compares — and which one we'd start with.
NuuVim
Cost-first shoppers who want low-cost compounded GLP-1s (injection or oral), flat all-dose pricing.
Visit NuuVimZappy Health
Shoppers who want both compounded and brand GLP-1 options on one platform and are comfortable weighing a recent FDA misbranding finding.
Visit Zappy HealthThe verdict
NuuVim takes it, leading the Cost-Efficiency Index 70 to 69. NuuVim is a Texas-based DTC telehealth program offering compounded semaglutide and tirzepatide in both injectable and oral forms — oral access is uncommon here — plus limited brand-name Ozempic and Zepbound. Zappy Health still earns a C — Shoppers who want both compounded and brand GLP-1 options on one platform and are comfortable weighing a recent FDA misbranding finding.
Worth knowing either way: our overall #1 pick is CoreAge Rx (Cost-Efficiency Index 94/100 — the top of the ranking). See how it stacks up: CoreAge Rx vs NuuVim.
Factor by factor
Both providers scored on our six Cost-Efficiency Index factors. The stronger side on each row is marked in teal.
Normalized Cost/Month
Price Transparency
Nationwide Access
Formulation Options
Clinical Oversight
Contract Flexibility
Pricing, coverage & formulary
The disclosed facts behind the scores. Lower price wins its row (teal).
| Spec | NuuVim | Zappy Health |
|---|---|---|
| Cost-Efficiency Index | 70/100 | 69/100 |
| Semaglutide / mo | $79/mo (all doses, 3-mo plan, new patients only, compounded) | $159/mo (starting dose, compounded) |
| Tirzepatide / mo | $133/mo (all doses, 3-mo plan, new patients only, compounded) | $279/mo (starting dose, compounded) |
| Semaglutide / yr (modeled) | $948 | $1,908 |
| Tirzepatide / yr (modeled) | $1,596 | $3,348 |
| Coverage | Coverage not published | 42 states |
| Oral / sublingual | Yes | No |
| Brand-name access | Yes | Yes |
| Rank here | #88 | #93 |
NuuVim
70/100Where the value is
- Low compounded entry pricing — semaglutide from $79/mo, tirzepatide from $133/mo, flat all-dose pricing
- Both injectable and oral compounded options for semaglutide and tirzepatide (oral access is uncommon)
- LegitScript Certified and HIPAA-compliant
The tradeoffs
- There is no month-to-month plan: every rate is billed as one three-month payment
- The advertised $79 and $133 are introductory rates for customers new to GLP-1s; on renewal they become $133 and $199.67
Zappy Health
69/100Where the value is
- Both compounded semaglutide/tirzepatide and brand Wegovy/Zepbound pathways offered on one platform
- No insurance or membership required; cash-pay pricing displayed before intake
- LegitScript badge displayed on the site
The tradeoffs
- Does not name its dispensing pharmacy
- No named medical director or prescriber found
Regulatory note: the FDA issued a warning letter to Kare Solutions, LLC dba Zappy in February 2026. We still list and link to Zappy Health; you should know the letter is on the public record before you decide.
Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Cost-Efficiency Index. Pricing, states and verification reflect each provider's public disclosures at last review; prices change — confirm on the provider's site. Not medical advice. See our disclosure.